| pubmed-article:16470607 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16470607 | lifeskim:mentions | umls-concept:C0019169 | lld:lifeskim |
| pubmed-article:16470607 | lifeskim:mentions | umls-concept:C0024299 | lld:lifeskim |
| pubmed-article:16470607 | lifeskim:mentions | umls-concept:C0019158 | lld:lifeskim |
| pubmed-article:16470607 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:16470607 | lifeskim:mentions | umls-concept:C0209738 | lld:lifeskim |
| pubmed-article:16470607 | lifeskim:mentions | umls-concept:C0199176 | lld:lifeskim |
| pubmed-article:16470607 | lifeskim:mentions | umls-concept:C0439793 | lld:lifeskim |
| pubmed-article:16470607 | lifeskim:mentions | umls-concept:C0392756 | lld:lifeskim |
| pubmed-article:16470607 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
| pubmed-article:16470607 | lifeskim:mentions | umls-concept:C1742737 | lld:lifeskim |
| pubmed-article:16470607 | lifeskim:mentions | umls-concept:C1514756 | lld:lifeskim |
| pubmed-article:16470607 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:16470607 | pubmed:dateCreated | 2006-3-8 | lld:pubmed |
| pubmed-article:16470607 | pubmed:abstractText | Hepatitis B virus (HBV) infection is a common disease in China. Severe hepatitis is a well recognized complication in HBV carriers with malignant disease who receive cytotoxic chemotherapy. The objective of the current study was to assess the value of antiviral lamivudine for reducing the incidence and severity of hepatitis in HBV carriers with lymphoma who receive chemotherapy. | lld:pubmed |
| pubmed-article:16470607 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16470607 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16470607 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16470607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16470607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16470607 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16470607 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16470607 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:16470607 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:16470607 | pubmed:author | pubmed-author:ZhangLiL | lld:pubmed |
| pubmed-article:16470607 | pubmed:author | pubmed-author:GuanZhong-Zhe... | lld:pubmed |
| pubmed-article:16470607 | pubmed:author | pubmed-author:JiangWen-QiWQ | lld:pubmed |
| pubmed-article:16470607 | pubmed:author | pubmed-author:HuangHui-Qian... | lld:pubmed |
| pubmed-article:16470607 | pubmed:author | pubmed-author:XiaZhong-JunZ... | lld:pubmed |
| pubmed-article:16470607 | pubmed:author | pubmed-author:LinXu-BinXB | lld:pubmed |
| pubmed-article:16470607 | pubmed:author | pubmed-author:LiYu-HongYH | lld:pubmed |
| pubmed-article:16470607 | pubmed:author | pubmed-author:SunXiao-FeiXF | lld:pubmed |
| pubmed-article:16470607 | pubmed:author | pubmed-author:HeYou-JianYJ | lld:pubmed |
| pubmed-article:16470607 | pubmed:author | pubmed-author:LinTong-YuTY | lld:pubmed |
| pubmed-article:16470607 | pubmed:author | pubmed-author:HeYi-FuYF | lld:pubmed |
| pubmed-article:16470607 | pubmed:author | pubmed-author:WangFen-HuaFH | lld:pubmed |
| pubmed-article:16470607 | pubmed:copyrightInfo | (c) 2006 American Cancer Society. | lld:pubmed |
| pubmed-article:16470607 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16470607 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:16470607 | pubmed:volume | 106 | lld:pubmed |
| pubmed-article:16470607 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16470607 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16470607 | pubmed:pagination | 1320-5 | lld:pubmed |
| pubmed-article:16470607 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:meshHeading | pubmed-meshheading:16470607... | lld:pubmed |
| pubmed-article:16470607 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16470607 | pubmed:articleTitle | Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma. | lld:pubmed |
| pubmed-article:16470607 | pubmed:affiliation | Department of Medical Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in Southern China, 651 Dong Feng Road East, Guangzhou 510060, People's Republic of China. | lld:pubmed |
| pubmed-article:16470607 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16470607 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:16470607 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16470607 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16470607 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16470607 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16470607 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16470607 | lld:pubmed |
